US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3400
  • +0.0100+0.75%
Close Apr 26 16:00 ET
  • 1.3303
  • -0.0097-0.72%
Post 19:10 ET
280.86MMarket Cap-4785P/E (TTM)

Akebia Therapeutics Key Stats

Akebia Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 14, 2024

Revenue(YoY)

56.20M

+0.74%
EPS(YoY)

<0.01

+108.04%

Strong Buy

Apr 18, 2024

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 49.512M--
--2024/Q1-- / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--
Aug 25, 20232023/Q256.376M / 59.101M--
May 8, 20232023/Q140.127M / 46.684M--
Mar 9, 20232022/Q455.180M / 47.399M--
Nov 3, 20222022/Q348.964M / 47.168M--
Aug 4, 20222022/Q2126.759M / 49.697M--
May 9, 20222022/Q161.699M / 44.224M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 49.512M--
--2024/Q1-- / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--
Aug 25, 20232023/Q256.376M / 59.101M--
May 8, 20232023/Q140.127M / 46.684M--
Mar 9, 20232022/Q455.180M / 47.399M--
Nov 3, 20222022/Q348.964M / 47.168M--
Aug 4, 20222022/Q2126.759M / 49.697M--
May 9, 20222022/Q161.699M / 44.224M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 18, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg